ABSTRACT: Fenneropenaeus indicus could be protected from white spot disease (WSD) caused by white spot syndrome virus (WSSV) using a formalin-inactivated viral preparation (IVP) derived from WSSV-infected shrimp tissue. The lowest test quantity of lyophilized IVP coated onto feed at 0.025 g -1 (dry weight) and administered at a rate of 0.035 g feed g -1 body weight d -1 for 7 consecutive days was sufficient to provide protection from WSD for a short period (10 d after cessation of IVP administration). Shrimp that survived challenges on the 5th and 10th days after cessation of IVP administration survived repeated challenges although they were sometimes positive for the presence of WSSV by a polymerase chain reaction (PCR) assay specific for WSSV. These results suggest that F. indicus can be protected from WSD by simple oral administration of IVP.
INTRODUCTION
Appropriate measures to manage white spot syndrome virus (WSSV) have been of great interest ever since its emergence as the single most important pathogen of cultivated shrimp. Despite the implementation of several management practices such as avoidance, optimization of culture conditions and application of immunostimulants, probiotics or vitamins, the disease continues to cause severe losses. The belief that invertebrates lack specific immunoglobulins has hindered deliberate attempts to vaccinate shrimp against WSSV (Faye 1990) . Although no antibodies have been detected in invertebrates, several molecules belonging to the immunoglobulin superfamily (IgSF) and involved in the immune response have been documented (Mendoza & Faye 1996) . These include adhesion molecules (Mendoza & Faye 1996) such as catherins, Ig-like proteins, extracellular matrix proteins, tiggrin (Johansson 1999) , peroxinectin (Johansson & Soderhall 1988 , Johansson et al. 1995 , haemolin (Sun et al. 1990 , Ladenhorff & Kanost 1991 , Bettencourt et al. 1997 , limulus agglutination-aggregation factor (LAF), hemocytin, A74 protein, croquemort, plasmocyte spreading peptide (PSPI) and Drosophila Toll/Cactus/Dorsal proteins (TCD) (AralaChaves & Sequeira 2000) . However, it is believed that shrimp and other crustaceans do not possess adaptive immunity but, rather, that they possess only an innate immunity that includes a diverse array of humoral and cellular factors. These include phagocytosis and melanization by activation of the prophenol oxidase activating system, clotting processes, encapsulation of foreign material, antimicrobial peptides, cytotoxic reactive oxygen intermediates (ROI) and agglutination. Non-self recognition factors include lectins, lipoproteins and cell to cell communication molecules (Soderhall & Cerenius 1992) .
Past research has focused primarily on understanding these non-specific crustacean defense mechanisms, and work on vaccines against specific pathogens such as WSSV has not been pursued seriously. Nevertheless, effective protection of Penaeus monodon and Marsupenaeus japonicus against vibriosis with formalin-killed Vibrio sp. has been reported (Itami et al. 1989 , Teunissen et al. 1998 . The mechanism of protection remains unexplained and may be an adaptive secondary immune response, homologous to that observed in vertebrates, or a distinct crustacean type of immunoprotective pathway (Arala-Chaves & Sequeira 2000) . The presence of bactericidins in P. monodon hemolymph after exposure to heat-killed V. alginolyticus has been reported (Adams 1991) and would seem to demonstrate some type of immune memory (Teunissen et al. 1998) . For viral pathogens, a process of specific and active viral accommodation has been postulated (Flegel & Pasharawipas 1998) . A requirement for the viral accommodation hypothesis was the existence of specific memory that could prevent viral triggered apoptosis but could not prevent viral infection. The hypothesis proposed that exposure of young larval stages to inactivated viral particles or sub-unit viral proteins ('tolerines' as opposed to vaccines) would result in innocuous, persistent viral infections rather than mortality upon subsequent viral challenge (Flegel & Pasharawipas 1998) .
A quasi-immune response to WSSV (known as penaeid rod-shaped DNA virus or PRDV in Japan) was reported for Marsupenaeus japonicus survivors from a farm outbreak of WSD that were able to survive a subsequent experimental super-challenge (Venegas et al. 2000) . Similar incidents have occurred on shrimp farms at Kerala, India, where successful harvests resulted after an earlier viral outbreak. These previous reports and our observations prompted us to examine the possibility of protecting shrimp against WSSV using a formalin-inactivated viral preparation (IVP). This work was originally submitted for publication in May 2003 but suffered publication delays. In the meantime, Namikoshi et al. (2004) claimed the first successful 'vaccination' in shrimp against WSSV by demonstrating protection of M. japonicus from WSSV by intramuscular injection of formalin-inactivated WSSV or recombinant viral protein rVP28. Later, Witteveldt et al. (2004a,b) reported similar results using 2 WSSV envelope proteins, VP19 and VP28. Our work is discussed in this context and its practical utility is examined.
MATERIALS AND METHODS
Virus strain. A strain of WSSV (MCCV101) from the microbial culture collection of the Centre for Fish Disease Diagnosis and Management, Cochin University of Science and Technology, India, was used for the experiment. This virus was originally isolated in 1995 from a Penaeus monodon spawner and was continuously passed through several batches of quarantined WSSV-free Fenneropenaeus indicus. It was stocked at -35°C in shrimp tissue. The virus was confirmed as WSSV by histopathology, electron microscopy and diagnostic nested PCR (Fig. 1) .
To generate a sufficient quantity of virus for experiments, frozen stock tissue was thawed and fed to quarantined Fenneropenaeus indicus maintained in rearing tanks as described below. Moribund shrimp were examined for characteristic white spots within the cuticle and then stored at -35°C until required for inactivated viral preparation (IVP).
Maintenance of experimental animals. Juvenile Fenneropenaeus indicus (average body weight of 3 to 4 g) were brought to the laboratory and quarantined for 48 h. Those that started eating pelleted diet were transferred to rearing tanks where salinity was gradually adjusted to 20 parts per thousand (ppt). They were subjected to stress testing by exposure to 100 ppm for- malin for 1 h before survivors only were returned to fiber reinforced plastic (FRP) rectangular tanks (30 l) for experiments. Water quality was monitored daily to maintain pH at 7.5 to 8.5, salinity at 20 to 22 ppt, NH 3 at 0.01 to 0.02 ppm, NO 2 at 0.1 to 0.2 ppm and dissolved oxygen at 6 to 7 mg oxygen l -1
. Water was partially exchanged whenever the values deviated. Aeration was provided through air spargers from a 746 W compressor. The shrimp were fed ad libitum twice daily with commercial pelleted feed (Grower).
Virus titre. Viral infectivity titre for Fenneropenaeus indicus was estimated as extractable virus g -1 of infected stock tissue and expressed as lethal dose (LD 50 ) following Reed & Muench (1938) . Briefly, 1 g WSSV MCCV101 infected stock tissue was thoroughly macerated in a minimum quantity of phosphate buffered saline (PBS) (8 g NaCl, 0.2 g KCl, 1.15 g Na 2 HPO 4 , 0.2 g KH 2 PO 4 , 1000 ml ddH 2 O) with an equal quantity of glass fibre wool and made into a slurry that was centrifuged at 8200 × g for 20 min at 4°C. The supernatant was removed, made up to 7 ml using PBS and filtered through a 0.22 µm polyvinylidene fluoride (PVDF) membrane (Millipore). From this filtered viral extract, serial dilutions were prepared up to 10 -20.85 using PBS. Dilutions (10 -1.85 to 10 -20.85
) were injected into batches of 6 shrimp (10 µl each) and the LD 50 g -1 of the infected tissue was calculated from the reciprocal of the dilution that caused 50% mortality.
Inactivated virus preparation. Infected stock tissue was homogenized in sterile seawater (2% salinity) at a ratio of 15 g to 100 ml in a tissue homogenizer and passed through a 100 µm mesh sieve to ensure uniformity. It was then subjected to 2 successive cycles of freezing and thawing to release virus from the tissue particles. To ensure that the suspension contained WSSV, 0.01 ml was injected into each of two 10 g healthy Fenneropenaeus indicus immediately after preparation. These were then observed for clinical signs of WSD and mortality for 10 d. The preparation was inactivated by addition of formalin (Qualigens) to a final concentration of 0.2% (v/v) and incubation at room temperature (28 ± 1°C) for 48 h. The IVP was then stored at 4°C until used. To examine for sterility, a loop-full of the IVP suspension was streaked onto ZoBell's and Sabouraud dextrose agar plates (prepared using 20 ppt seawater) that were incubated for 7 d. As a control (placebo), head soft tissue of apparently healthy animals (tested negative by diagnostic PCR) was treated as above and maintained at 4°C until used. Aliquots of 10 ml preparations (both test and placebo) were absorbed onto 5 g of pelleted feed (Grower), air dried briefly and continuously fed to batches of 8 juveniles in triplicate for 9 d at intervals of 24 h. All animals were observed to ensure lack of clinical signs of WSD and lack of mortality for 7 d.
Efficacy of IVP in preventing WSD. IVP and the placebo were lyophilized (FTS Systems) to yield 35.6 g dry mass from 500 ml of tissue suspension prepared from 75 g of infected tissue. The lyophilized material was coated onto pelleted feed (Grower) at a ratio of 1:10 (w/w) using a commercial binder ('Bindex', Matrix Vet Pharma) at a ratio of 0.1:10 v/w and dried in vacuum desiccator for 2 d. After drying, the preparation was maintained in airtight containers at 4°C.
Twelve FRP tanks (25 l) were set up with 4 shrimp in each. Four tanks received IVP coated feed, 4 placebo, and 4 normal feed. Feeding was ad libitum but was later determined to be 0.035 g feed g -1 body weight d -1
. Feeding was continued for 7 d before all tanks were switched to normal feed. There was no cannibalism. The shrimp were challenged (1 tank at a time for each group) on the 1st, 5th, 10th and 15th day after the completion of the initial 7 d administration schedule. Thawed WSSV MCCV101-infected shrimp meat maintained at -35°C was used for the challenge at a rate of approximately 1 g infected tissue for 4 animals. This was given after all uneaten feed and fecal matter had been removed and after partial water exchange. On all other days, the shrimp were maintained on a normal diet. After challenge, the shrimp were observed for clinical signs of the disease and mortality for 10 d. The experiment was repeated 6 times. Shrimp that survived the 5th and 10th day challenges were subjected to repeated WSSV MCCV101 prawn meat challenges at intervals of 15 d for 4 consecutive times.
Quantity of IVP required. Initial tests used IVP incorporated into the feed at 1:10 (w/w) and the feed was consumed at a rate of 35 g kg -1 shrimp body weight d -1
. Further tests were carried out to determine the minimum quantity of IVP required for WSD protection. Accordingly, tests were repeated in batches of 12 as described above but using experimental diet coated with 0.25, 0.5, 0.75 and 1.0 g of lyophilized IVP per 10 g feed. Corresponding control sets of animals were maintained on a normal diet. The overall duration of IVP administration was 7 d and the shrimp were challenged in 2 consecutive steps, half on the 5th day after completion of IVP administration and half on the 10th day. The experiment was repeated 3 times.
PCR testing for WSSV. Gill samples from shrimp that survived viral challenges were pooled and tested for the presence of WSSV employing a WSSV 2-step nested PCR detection kit (Bangalore Genei) that yields 650 and 300 bp WSSV-specific amplicons. The PCR products were then analyzed on 2% w/v agarose gels using TAE (1X) as the running buffer (Tris-HCl 0.04 M, EDTA 0.0001 M, glacial acetic acid 5.71%), staining by ethidium bromide and visualization on a UV transilluminator (Hoefer, Macro Vue UV-20). Following the kit instructions, the expected amplicons were obtained using an MJ Research, PTC-150 thermocycler with stored WSSV MCCV101 samples.
RESULTS
The viral titre for LD 50 of the WSSV MCCV101 viral extract solution was 1 × 10 13.69 ml -1 of inoculum. This value could be used to calculate that the WSSV titre of the WSSV MCCV101 tissue used was 7 × 10 13.69 g -1 (wet weight). Accordingly the titre of the lyophilized IVP was calculated to be 14.75 × 10 13.69 g -1 (dry weight). The IVP was shown to contain no viable WSSV after treatment with formalin (0.2% v/v) for 48 h at room temperature since there was 100% survival during a period of 7 d for the shrimp (batches of 8 in triplicate) fed with the preparation. No bacterial or fungal growth was observed in any of the inactivated virus suspensions streaked onto standard media plates.
Shrimp challenged with WSSV on the 5th and 10th day after cessation of feeding with IVP showed 100% survival, while those challenged on the 1st and 15th day after cessation suffered mortality, with clinical manifestations of WSD (Table 1) . Likewise, all WSSVchallenged shrimp in normal feed control and placebo control suffered total mortality and exhibited clinical signs of WSD within 10 d of challenge. On examining the efficacy of IVP required to elicit a response, it was found that the lowest effective quantity was 0.025 g IVP dry weight (LD 50 3.69 × 10 12.69 ) g -1 feed ( Table 2 ). Shrimp that survived challenge after the IVP administration schedule also showed 100% survival and absence of gross signs of WSD upon 4 subsequent challenges carried out consecutively at 15 d intervals with WSSV-infected prawn meat.
Shrimp that survived WSSV challenge on the 5th day after completion of the IVP administration schedule were tested on the 10th day post challenge for the presence of WSSV by single step and nested PCR assays. None gave positive results (Fig. 2) . In contrast, the gill tissue of animals challenged on the 10th day after the completion of administration of IVP gave amplicons for the first step PCR (650 bp amplicon) and second step (nested) PCR (300 bp amplicon) (Fig. 2) . Despite the positive test results, the shrimp appeared healthy and showed no gross signs of disease and no mortality.
DISCUSSION
Formalin was used to inactivate WSSV because of its ability to cross-link proteins and to stabilize antigenic epitopes (Wesslen et al. 1957 , Bottiger et al. 1958 , Barteleng & Woortmeyer 1984 . Formalin treatment was found to be better for enhancing WSSV resistance than heat treatment as used by Namikoshi et al. (2004) . The optimum treatment for virus inactivation after successive freezing and thawing cycles was 48 h exposure to 0.2 % v/v formalin. However, the preparation was maintained at 4°C for 9 d to ensure total inactivation of the virus and any bacteria and fungi that might also have been present in the shrimp tissue macerates. The shrimp fed IVP for 7 d were found to resist WSSV infection from 5 d and until 10 d after feeding but before and after this, they were vulnerable to infection and subsequent death. The protective effect did not arise from normal shrimp tissue (placebo) components. The 7 d schedule of IVP administration was adopted based on the work of Takahashi et al. (2000) , who found it most effective for oral administration of immunostimulants. A similar requirement of a few days to elicit an immunological response has previously been reported (Sung et al. 1994 , Teunissen et al. 1998 .
Since shrimp that survived WSSV challenge on the 5th day after cessation of IVP feeding were negative for WSSV by nested PCR assays, the results suggest that they were refractory to WSSV for at least some interval following IVP administration. This refractory interval is comparable to that which occurs in vertebrates and is mediated by immunoglobulins that react with specific antigens and facilitate their elimination by subsequent phagocytosis. The results are similar to those of Adams (1991) and Teunissen et al. (1998) described in the 'Introduction' and suggest the possibility of some sort of memory for different pathogens in shrimp. Therefore, we propose to focus subsequent research on tests for the existence of specific molecules that might be produced in response to inactivated WSSV and bind with it to facilitate its elimination by subsequent phagocytosis. Should such molecules be discovered, they might be named 'viricidins'. Surprisingly, a different result was obtained with shrimp that were challenged 10 d after cessation of IVP feeding. Instead of being negative for WSSV by PCR, they were positive even by a single-step assay although they showed no signs of disease. This suggested that they were able to accommodate WSSV and survive. This situation resembled viral accommodation as proposed by Flegel & Pasharawipas (1998) and experiments on a quasi-immune response (Venegas et al. 2000 , Namikoshi et al. 2004 , Witteveldt et al. 2004a as described in the 'Introduction'. As part of the quasi-immune response, a cell-mediated defense mechanism has been proposed by Hasson et al. (1999) . Wu et al. (2002) also demonstrated WSSV neutralizing activity in plasma of infected shrimp from 20 d to more than 2 mo. Namikoshi et al. (2004) concluded that the quasi-immune response molecule was heat labile. These studies and our observations confirm the phenomenon of acquired resistance or a quasi-immune response in shrimp. In addition, our detection of WSSV-PCR positive survivors from a WSSV challenge 10 d following cessation of IVP feeding exactly matches the observations of Venegas et al. (2000) .
Our study indicates the existence of 4 phases in the immune response of shrimp, subsequent to administration of IVP, even though the beginning and end of these phases could not be sharply demarcated. These phases are named the 'immune activation phase' (1st to 4th day post IVP administration), the 'refractory phase' (5th to 9th day post IVP administration), the 'viral accommodation phase' (10th to 14th day post IVP administration) and the 'immune declining phase' (15th day onwards). The lack of clear demarcation between phases may result from variation in different batches of shrimp but could not be gauged in our experimental design. Despite this, the demarcations may be useful in analyzing results from further investigations.
The concept of protecting shrimp from WSSV by oral administration of IVP gains added support from the observation that they subsequently survive repeated challenges with WSSV. The subsequent challenges could be regarded as broadly equivalent to booster 'vaccinations' in vertebrates. Thus, despite lack of knowledge on the shrimp immune system, available information suggests that periodic oral administration of IVP or envelope proteins such as VP19 and VP28 (Witteveldt et al. 2004b ) at 10 d intervals may prolong protection against WSSV. The process of IVP administration may be economically viable since the quantity required for eliciting a response in recipient shrimp is very small (0.025 g IVP g -1 feed w/w having an approximate virus titre LD 50 3.68 × 10 12.69 ). The term 'vaccine' denotes any substance used to stimulate the production of antibodies that result in immunity to a specific disease. In shrimp, antibody-like molecules that specifically bind with a respective antigen have not been discovered. Therefore, it would be premature to call the inactivated WSSV preparation a 'vaccine' and that is why we describe it as an inactivated virus preparation (IVP). This contrasts with the nomenclature previously used with the WSSV recombinant envelope proteins VP9 and VP28 that were referred to as sub-unit vaccines (Witteveldt et al. 2004a,b) . Despite the fact that the mechanisms is unknown, this investigation and previous studies unequivocally reveal that shrimp have a true adaptive and specific immune response that can be elicited by repeated oral administration of IVP and result in protection against WSD. A major point of interest is that protection against WSD does not always equate to absence of WSSV infection.
